Breaking News

Pall, Aetos Partner to Deliver Biosimilar Mfg. Solutions

Will combine bioprocessing equipment with high-quality/high-titer cell lines and scalable manufacturing processes

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pall Corp’s Biotech business has entered a strategic partnership with Aetos Biologics a biosimilar cell line development company, to offer biosimilar manufacturing solutions. Pall Biotech will provide access to next generation bioprocess equipment, such as the Allegro STR Single-use Stirred Tank Bioreactor for GMP manufacturing, and consumables for biosimilar production. Aetos Biologics will provide high-quality/high-titer cell lines, and scalable manufacturing processes. “Biosimilars are a r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters